News

Under the terms of the agreement, Smiths will provide Applied DNA Sciences (APDN) with exclusive use of the Bio-seeqPLUS platform, centered upon a portable, DNA-verifying device for authentication,

The aesthetic outcome of injections with the Aquamid hydrogel showed that 96% of the 116 patients evaluated after five years had ‘very good’ or ‘good’ aesthetic results according

Neuronal nicotinic receptors (NNRs) are a class of proteins in the nervous system that modulate the levels of key chemical messengers, such as dopamine. Nicotine’s addictive effects have

The granting of conditional investigational device exemption (IDE) approval by the FDA enables the company to immediately commence its US clinical trial for the HeartWare Left Ventricular Assist

The double-blind, placebo-controlled study was designed to compare the efficacy and safety of four different dosage regimens of Q8003IR, a fixed ratio morphine/oxycodone combination. Among all patients receiving

Saturn is a 104-week, parallel-group, multicentre, double-blind, Phase IIIb intravascular ultrasound (IVUS) imaging study of approximately 1,300 patients at 170 centres worldwide. This study by AstraZeneca is designed

The double-blind, placebo-controlled study showed that ROX-888 rapidly and effectively eased pain among patients who had undergone major abdominal or orthopedic surgery. In addition, ROX-888 significantly reduced the

The studies were performed at a Bio-Safety Level 3 Laboratory (BSL-3) facility in Boston, Massachusetts. The company’s scientists are now designing the protocol for a follow up anti-HIV

GDC-0449 will be evaluated in approximately 150 patients with metastatic colorectal cancer in combination with the current standard of care in a randomized, placebo-controlled, double-blind Phase II trial.